Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Ricciardolo (Bergamo, Italy). Targeting the arginase pathway: potential developments as new avenues for treatment. Annual Congress 2004 - Arginase: a novel target and marker for asthma?

Member's Comments

No comment yet.

Related content which might interest you: COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Bringing it all together: common pathways, emerging therapeutics and future directions Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease Year: 2014 Targeting mucus as a new therapeutic avenue? Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner? Year: 2011 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma Source: Eur Respir J, 53 (2) 1802444; 10.1183/13993003.02444-2018 Year: 2019 Targeting metabolic reprogramming as a novel anti-fibrotic strategy Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities Source: Eur Respir J 2014; 44: 513-522 Year: 2014 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020 How to stop LC-fILD progression: an overview of modern therapeutic strategies Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Exploring new frontiers: the role of simulation as an educational strategy Source: Breathe 2013; 9: 497-501 Year: 2013 How to disrupt malicious LC-fILD pathways: antifibrotic agents as a promising therapeutic approach Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021